Is the Comet Assay a Sensitive Procedure for Detecting Genotoxicity? by Kawaguchi, Satomi et al.
SAGE-Hindawi Access to Research
Journal of Nucleic Acids
Volume 2010, Article ID 541050, 8 pages
doi:10.4061/2010/541050
Research Article
Is the Comet Assay a Sensitive Procedure for
DetectingGenotoxicity?
Satomi Kawaguchi,1 Takanori Nakamura,2 Ayumi Yamamoto,1 GishoHonda,2
andYu F.Sasaki1
1Laboratory of Genotoxicity, Faculty of Chemical and Biological Engineering, Hachinohe National College of Technology,
Uwanotai 16-1, Hachinohe, Aomori 039-1192, Japan
2Department of Pharmaceutical Health Care, Faculty of Pharmaceutical Sciences, Himeji Dokkyo University, Kamiohno 7-2-1,
Himeji, Hyogo 670-8524, Japan
Correspondence should be addressed to Yu F. Sasaki, yfsasakiaugsta@yahoo.co.jp
Received 30 May 2010; Revised 9 September 2010; Accepted 4 October 2010
Academic Editor: Shigenori Iwai
Copyright © 2010 Satomi Kawaguchi et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Although the Comet assay, a procedure for quantitating DNA damage in mammalian cells, is considered sensitive, it has never
been ascertained that its sensitivity is higher than the sensitivity of other genotoxicity assays in mammalian cells. To determine
whether the power of the Comet assay to detect a low level of genotoxic potential is superior to those of other genotoxicity
assays in mammalian cells, we compared the results of Comet assay with those of micronucleus test (MN test). WTK1 human
lymphoblastoid cells were exposed to methyl nitrosourea (MNU), ethyl nitrosourea (ENU), methyl methanesulfonate (MMS),
ethyl methanesulfonate (EMS), bleomycin (BLM), or UVC. In Comet assay, cells were exposed to each mutagen with (Comet
assay/araC) and without (Comet assay) DNA repair inhibitors (araC and hydroxyurea). Furthermore, acellular Comet assay
(acellular assay) was performed to determine how single-strand breaks (SSBs) as the initial damage contributes to DNA migration
and/or to micronucleus formation. The lowest genotoxic dose (LGD), which is deﬁned as the lowest dose at which each mutagen
causes a positive response on each genotoxicity assay, was used to compare the power of the Comet assay to detect a low level of
genotoxic potential and that of MN test; that is, a low LGD indicates a high power. Results are summarized as follows: (1) for all
mutagens studied, LGDs were MN test  Comet assay; (2) except for BLM, LGDs were Comet assay/araC  MN test; (3) except
for UVC and MNU, LGDs were acellular assay  Comet assay/araC  MN test  Comet assay. The following is suggested by the
present ﬁndings: (1) LGD in the Comet assay is higher than that in MN test, which suggests that the power of the MN test to detect
a low level of genotoxic potential is superior to that of the Comet assay; (2) for the studied mutagens, all assays were able to detect
all mutagens correctly, which suggests that the sensitivity of the Comet assay and that of the MN test were exactly identical; (3) the
power of the Comet assay to detect a low level of genotoxic potential can be elevated to a level higher than that of MN test by using
DNA resynthesis inhibitors, such as araC and HU.
1.Introduction
Many methods have been used to identify genotoxic sub-
stances, including the detection of DNA damage, chromo-
some aberrations, and gene mutations both in vitro and
in vivo. The Comet assay, which can detect single-strand
breaks (SSBs) as initial damage and those developed from
alkali-labile sites under alkaline condition (pH > 12.6), is
a rapid and sensitive procedure for detecting genotoxicity
in mammalian cells [1, 2]. When the sensitivity of a
genotoxicity testing method is regarded as high, it means
that it can detect wide variety of compounds with unknown
genotoxic potential and that the assay can detect a low level
of genotoxic potential by known genotoxic compounds. The
former is very important in order to avoid pseudonegative
results. In general, therefore, compounds with unknown
genotoxic potential are assayed at a high dose, including
maximum tolerated (subtoxic) dose. The genotoxic dose
response curve for genotoxic compounds is thought to
reach zero without having a no-response level at a low2 Journal of Nucleic Acids
dose. This statement forms the basis of the “nonthreshold
concept” in the risk assessment, which describes the absence
of a threshold in genotoxic potential. The “nonthreshold
concept” for genotoxic compounds means that these agents
could have an inﬂuence on humans even at very low-levels
[3].Therefore,itisimportanttodetectlowlevelgenotoxicity.
Although the Comet assay is considered highly sensitive
[1, 2], it has not been well ascertained whether its sensitivity
todetectgenotoxicityishigherthanthatofotherprocedures.
AlthoughtheCometassayisessentiallyamethodofdetecting
single-strand breaks (SSBs), we have shown that a low level
of SSB as the initial damage cannot be detected by the Comet
assay because these SSBs disappear following a repair event
and that SSBs as initial DNA damage can be well detected
in the acellular Comet assay (acellular assay) [4]. The Comet
assaycandirectlydetectnotonlySSBsasinitialDNAdamage
but also SSBs that develop from alkali-labile sites under
alkaline condition (pH > 12.6) and that formed during
repairofbaseadductsoralkylatedbases,whicharenotinitial
DNA damage [5] .T h em i c r o n u c l e u st e s t( M Nt e s t )i sa
standard procedure that can detect structural chromosome
aberrationsderivedfrominitialdamageintheSphaseand/or
numerical chromosome aberrations due to aneugenic eﬀects
in the M phase [6, 7]. Pfau et al. [8] conducted combined
experimentswithMLC5cellsincludingCometassayandMN
test and showed that the genotoxicity of heterocyclic amines
was observed at concentrations that were 2000-fold lower on
MN test than on Comet assay. However, Van Goethem et
al. showed that the lowest genotoxic concentrations of pure
cobaltpowder,acobalt-containingalloy,andcobalt-tungsten
carbide were lower on Comet assay than on MN test [9].
Hartmann et al. [10] tested 36 pharmaceutical compounds
with unknown genotoxic potential comparatively in the
Comet assay and MN test using V79 Chinese hamster cells
and reported that more compounds were positive in the
MN test than in the Comet assay. Kawaguchi et al. [11]
conducted combined experiments with TK6 and WTK1 cells
including the Comet assay, chromosome aberration assay,
and TK mutation assay and showed that the genotoxicity of
kojic acid was observed at 2500μg/mL on Comet assay and
the chromosome aberration test and at 1250μg/mL on TK
mutation assay. However, the exposure conditions used in
some of those studies diﬀered among diﬀerent assays (Pfau
et al. [8] exposed cells for 30min and 24h in the Comet
assay and MN test, resp.) and model mutagens with well-
characterized action mechanisms were not used, making it
diﬃcult to systematically compare the sensitivities of those
assays including the Comet assay. In our series of studies
using well-known mutagens, we showed that SSBs as initial
damage can be well detected by acellular assay but not by
Comet assay under standard condition [4] and that the
response of Comet assay to mutagens inducing DNA damage
that can be repaired by the excision repair system tended
to be aﬀected by p53 status [12]. Here, to discuss whether
that the power of the Comet assay to detect a low level
of genotoxic potential is superior to that of MN test, we
conducted combined experiments with TK6 cells including
(standard) Comet assay, acellular assay, and MN test under
identical exposure conditions.
2.MaterialsandMethods
2.1. Chemicals. Methyl methanesulfonate (MMS) and ethyl
methanesulfonate (EMS) were obtained from Sigma Chem-
icals Inc., St. Louis, MO (U.S.A.). Methyl nitrosourea
(MNU) and ethyl nitrosourea (ENU) were purchased from
Nacalai Tesque, Inc., Kyoto (Japan). They were dissolved
in dimethyl sulfoxide (DMSO, Wako Pure Chemical Indus-
tries, Ltd., Osaka). Bleomycin (BLM, Wako Pure Chemical
Industries, Ltd.) was dissolved in physiological saline. The
DNA repair inhibitors hydroxyurea (HU) and cytosine-1-
β-D-arabinofuranoside (araC), purchased from Wako Pure
Chemical Industries, Ltd., were dissolved in physiological
saline.Regular(GP-42)andlowmeltingpoint(LGT)agarose
were obtained from Nacalai Tesque, Inc. and were diluted to
1% in physiological saline.
2.2. Cells. TK+/− heterozygote of the TK6 human lym-
phoblastoid cells exhibiting wild-type p53 (generously
donatedbyDr.Honma,NationalInstituteofHealthSciences,
Tokyo) were used. Cells were maintained in logarithmic
growth using RPMI 1640 medium (Nissui Pharmaceutical
Co., Ltd.) supplemented with 10% horse serum (SAFC
Biosciences), 200μg/mL sodium pyruvate, and 200μg/mL
streptomycin at 37◦Cu n d e ra5 %C O 2 atmosphere.
2.3. Cell Treatment with Mutagens. Cells were centrifuged
and resuspended in a culture medium at a concentration of
5×105 cells/mL,and1mLofcellsuspensionscontainingeach
chemical mutagen were incubated for 2h in the presence
(Comet assay/araC) or absence (Comet assay) of the DNA
repair inhibitors araC (1.8mM) and HU (10mM). (The two
inhibitors were used at concentrations that did not induce
signiﬁcant reductions in cell viability [12].) On Comet
assay and Comet assay/araC, exposed cells were sampled
immediately after chemical treatment, and the percentage
of viable cells was measured by the trypan blue exclusion
test. Relative survival (survival under each concentration
compared with that of an untreated control) was obtained.
For UVC irradiation, 1mL of cell suspension in saline (5 ×
105 cells/mL) in a 6-cm dish was irradiated with a germicide
lamp (National GL15, 15W, Matsushita Electric Industrial
Co., Japan), as the UVC source from a distance of 15cm.
Irradiated cells were incubated for 2h in fresh medium with
(Comet assay/araC) or without (Comet assay) DNA repair
inhibitors (araC and HU) and then sampled.
2.4. Comet Preparation. Treated cells were suspended in
1% agarose-LGT at 5 × 105 cells/75μL, and 75μLo fc e l l
suspensionwasimmediatelydepositedonafullyfrostedslide
(MatsunamiGlassInd.,Ltd.,Osaka,Japan)whichwascoated
with 1% agarose GP-42 and then covered with another slide
glass. Although 0.5% LGT agarose is generally used, 1% LGT
agarose (Nacalai Tesque, Inc.) was used in this study. In the
caseofLGTagaroseobtainedfromNacalaiTesque,Inc.,0.5%
LGT is too soft to be used routinely in this assay. Although
DNA migration tended to be lower in 1% LGT than in 0.5%
LGT, there was no qualitative diﬀerence in the responses ofJournal of Nucleic Acids 3
thisassayin0.5%and1%(Figure 4),whichiswhy0.5%LGT
agarose was used.
The slides were placed so as to allow the agarose to gel.
The samples on the slides were then immediately exposed
to a lysing solution (pH 10) of 2.5MNaCl, 100mMEDTA
disodium (Na2EDTA), 10mM Trizma, 1% sarkosyl, 10%
DMSO, and 1% Triton X-100 and incubated at 4◦Cf o r
1h. The slides were then placed on a horizontal gel elec-
trophoresis platform and covered with pH > 13 alkaline
solution composed of 300mMNaOH and 1mMNa2EDTA.
T h es l i d e sw e r el e f ti ns o l u t i o na t0 ◦Cf o r2 0m i nt oa l l o w
unwinding of the DNA and expression of alkali-labile sites
to occur. The power supply was set at 1V/cm and 250mA.
The DNA was subjected to electrophoresis at 0◦C for 20min,
and the slides were rinsed with 400mM Trizma (pH 7.5) to
neutralize the excess alkalinity. Each slide was stained with
50μLo f2 0μg/mL ethidium bromide (Wako Pure Chemical
Industries, Ltd.) and covered with a coverslip. One hundred
cellsontwoslidesperdose(twoslideswerepreparedforeach
dose) were examined and photographed (black and white
ASA400Fujiﬁlm)at200xmagniﬁcationusingaﬂuorescence
microscope (Olympus) equipped with G ﬁlter. The whole
length of the Comet (“migration”) was measured.
The measures of DNA migration include many parame-
ters [13]: % of damaged cells (i.e., cells with tails), damaged
categories (classiﬁed into various types or intensities based
on shape), length of DNA migration (total or tail), and tail
moment (e.g., amount of tail DNA x tail length). Although
the use of % tail DNA is recommended [13], we used the
whole length of the Comet as a unique parameter. Although
the Comet image length is likely to be quantitatively inferior
to % tail DNA, its qualitative power to diﬀerentiate positive
and negative responses is not unsuitable and no parameters
are unacceptable [13]. In this study, the responses on Comet
assaywerenotanalyzedquantitatively.LGDsfortwoversions
of the Comet assay and MN test were obtained from
qualitative analysis of the results (diﬀerentiation between
positive and negative responses at each dose). Therefore, use
of the whole length of the Comet as a unique parameter is
not considered to have aﬀected the results of this study.
The eﬀect of chemical treatment on migration was ana-
lyzed using ANOVA and Dunnett test. The lowest genotoxic
dose (LGD) was deﬁned as the lowest dose where DNA
migrationincreasedsigniﬁcantly.Inthisstudy,LGDwasused
to compare the power of each assay to detect a low level of
genotoxic potential of each mutagen; that is, low LGD shows
high power.
2.5. Acellular Comet Assay (Acellular Assay). Slides for the
Comet assay from untreated TK6 cells were prepared as
outlined above and the slides were lysed immediately in a
lysing solution at 4◦C for one hour as described above. Lysed
slides were neutralized in 400mM Tris HCl buﬀer (pH 7.5)
for 15min and exposed to RPMI 1640 medium with 10%
horse serum containing diﬀerent concentrations of the test
agents for 2h at 37◦C in the dark. After the treatment period,
the slides were rinsed by immersion in cold distilled water,
and then the slides were electrophoresed at pH > 13 and
0◦C for 20min after unwinding of the DNA at pH > 13 for
20min. The power supply was set at 1V/cm and 250mA. In
the Comet assay, although SSBs could be diﬀerentiated from
alkali-labile lesions derived from base lesions; SSBs could be
detected by electrophoresis at pH 12.1 and both SSBs and
alkali-labile lesions by electrophoresis at pH > 13 [14]. DNA
damage detected under the acellular condition at both pH
12 and pH > 13 were shown to be SSBs but not alkali-
labile lesions, and there were no diﬀerences in the responses
of the acellular assay at pH > 13 from those at pH12 [15],
which is why electrophoresis was conducted at pH > 13.
For UVC irradiation, neutralized slides were irradiated by
a germicide lamp (National GL15, 15W, Matsushita Electric
Industrial Co., Japan) from a distance of 15cm. Irradiated
slides were incubated for 2h in 400mM Tris HCl buﬀer
immediately after UVC-irradiation, and then the slides were
electrophoresed at pH > 13 as described above.
2.6. Micronucleus Test (MN Test). Cells were exposed to each
mutagen as described above. At the end of a treatment
period, the cells were washed with Hanks’ BSS and cultured
for 24h in medium containing cytochalasin B at 3μg/mL,
and then cells were sampled. For UVC irradiation, 1mL of
cell suspension in saline (1 × 106 cells/mL) in 6-cm dish
was irradiated by a germicide lamp (National GL15, 15W,
Matsushita Electric Industrial Co., Japan) as the UVC source
from a distance of 15cm. Irradiated cells were incubated
for 24h in medium containing cytochalasin B at 3μg/mL,
and then cells were sampled. The collected cells were
suspended in 0.075MKCl hypotonic solution for 15min,
the cell suspension was concentrated to a volume of 1mL,
mixed with 1mL of 10% neutral buﬀered formalin solution
and then concentrated to a volume of 100μL. The cell
suspension was further mixed with 100μLo f0 . 0 5 w / v %
aqueous solution of acridine orange, and then 50μLo fc e l l
suspensionwasplacedonaslideglassandmountedwith24×
48mmcoverslips.Binucleicellswithmicronuclei(MNBNC)
per 2000 binuclei cells (BNC) and BNC per 2000 cells were
scored with the aid of ﬂuorescence microscope (Olympus at
600x magniﬁcation) equipped with a B ﬁlter. The prevalence
of MNBNC was analyzed statistically by χ2 test. The lowest
genotoxic dose (LGD) was deﬁned as the lowest dose at
which MNBNC increased signiﬁcantly.
3. Results
Results of the Comet assay and Comet assay/araC are shown
in Figure 1. Results of acellular assay and MN test are shown
in Figures 2 and 3, respectively. LGDs are summarized in
Table 1.
Both in Comet assay and Comet assay/araC, BLM,
alkylating agents (MMS, EMS, MNU, and ENU), and UVC
increased DNA migration signiﬁcantly. In general, detection
of DNA migration was greater on Comet assay/araC than on
Cometassay.BothintheCometassayandCometassay/araC,
relative survivals were >70% in the dose range of studied
mutagens (data not shown). On acellular assay, BLM and
alkylating agents, but not UVC, increased DNA migration4 Journal of Nucleic Acids
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Figure 1: Comet assay and Comet assay/araC in TK6 cells. Slides for Comet assay were prepared immediately after the exposure to chemical
mutagens for 2h with or without araC/HU, or 2h culture with or without araC/HU after UVC irradiation. Electrophoresis was conducted
at pH > 13. Reproducibility was ascertained by three independent experiments, and representative data are shown. The error bars indicate
standard errors of the mean.
∗Signiﬁcant diﬀerence from untreated control: P<. 05.
Table 1: LGDs for Comet assay, Comet assay/araC, acellular assay, and MN test using TK6 cells.
Mutagen
LGD (μg/mL or J/m2) Ratio of LGD
Comet assay Comet assay/araC acellular assay MN test (Comet assay: MN test)
UVC 20 2.5 — 15 1.3
MNU 25 3.125 6.25 12.5 2
ENU 250 62.5 31.3 125 2
MMS 40 20 10 20 2
EMS 125 62.5 62.5 125 1
BLM 12.5 6.25 0.0625 5 2.5
signiﬁcantly. On MN test, BLM, alkylating agents, and UVC
increased MNBNC signiﬁcantly.
For BLM, LGDs were 12.5μg/mL, 6.25μg/mL, 0.0625μg/
mL, and 5μg/mL in the Comet assay, Comet assay/araC,
cellular assay, and MN test, respectively; that is, LGDs were
acellular assay < MN test < Comet assay/araC < Comet
assay. For MMS, LGDs were 40μg/mL, 20μg/mL, 10μg/mL,
and 20μg/mL on Comet assay, Comet assay/araC, acellular
assay, and MN test, respectively; that is, acellular assay <
Comet assay/araC = MN test < Comet assay. For EMS, LGDs
were 125μg/mL, 62.5μg/mL, 62.5μg/mL, and 125μg/mL
on Comet assay, Comet assay/araC, acellular assay, and
MN test, respectively; that is, acellular assay = Comet
assay/araC < MN test = Comet assay. For MNU, LGDsJournal of Nucleic Acids 5
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Figure 2:AcellularassayinTK6cells.SlidesforCometassaywereexposedtoeachchemicalmutagenfor2horirradiatedwithUVC,andthen
electrophoresis was conducted at pH > 13 immediately after exposure to the chemical mutagen or 2h after UVC irradiation. Reproducibility
was ascertained by three independent experiments and representative data are shown. The error bars indicate standard errors of the mean.
∗Signiﬁcant diﬀerence from untreated control: P<. 05.
were 25μg/mL, 3.125μg/mL, 6.25μg/mL, and 12.5μg/mL on
Comet assay, Comet assay/araC, acellular assay, and MN test,
respectively; that is, Comet assay/araC < acellular assay <
MN test < Comet assay. For ENU, LGDs were 250μg/mL,
62.5μg/mL, 31.3μg/mL, and 125μg/mL on Comet assay,
Comet assay/araC, acellular assay, and MN test, respectively;
that is, acellular assay < Comet assay/araC < MN test <
Comet assay. For UVC, LGDs were 20J/m2,2 . 5 J / m 2,a n d
15μg/mL on Comet assay, Comet assay/araC, and MN test,
respectively; that is, Comet assay/araC < MN test < Comet
assay.
4. Discussion
The present results are summarized as follows: (1) for all
mutagens studied, LGDs were MN test  comet assay; (2)
except for BLM, LGDs were Comet assay/araC  MN test;
(3) except for UVC and MNU, LGDs were acellular assay
 Comet assay/araC  MN test  Comet assay. Therefore,
despite the belief in the high sensitivity of Comet assay, its
power in detecting a low level of genotoxicity was lower
than that of MN test. Although the development of initial
damage into alkali-labile sites following repair events is an
important factor supporting the sensitivity of Comet assay, it
is easily assumed that DNA resynthesis and rejoining events
following SSB formation reduce the sensitivity of Comet
assay in detecting DNA damage such as alkylated bases and
bulky base adducts. In this study, we used two methods of
canceling the eﬀects of DNA resynthesis and/or rejoining
events. One is acellular assay [16] and the other is the use
of DNA repair inhibitors (araC and HU) [5, 17]. Acellular
assay is a modiﬁed version of Comet assay, in which slides
withgelspreparedfromuntreatedcellsareexposed afterlysis
to test agents and then processed according to the standard
protocol of the Comet assay. In the acellular assay, since lysed
cells are exposed to test compounds, there are no biological
events acting on the formation and/or disappearance of SSBs
[4, 16]. In our previous study, where positive responses on
Comet and acellular assays were detected at pH 12 and
>13, there were no apparent pH eﬀects on acellular assay,
suggesting that SSBs as initial DNA damage are detected on
acellular assay at pH 12 and pH > 13 [15].6 Journal of Nucleic Acids
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Figure 3: MN test in TK6 cells. TK6 cells were exposed to each chemical mutagen for 2h or irradiated with UVC and were incubated for
24h with cytochalasin B, and then slides for MN test were prepared. Reproducibility was ascertained by three independent experiments and
representative data are shown.
∗Signiﬁcant diﬀerence from untreated control: P<. 05.
When SSBs as initial DNA lesions are not rejoined, they
would be responsible for DNA migration on Comet assay.
For SSB-inducers such as BLM [18]; therefore, migration
would be observed on acellular assay, while rejoining of SSBs
before the preparation of the Comet assay would reduce
positiveresponseonCometassay.IfthelevelofSSBsasinitial
DNA damage is high enough to persist until the preparation
of the Comet assay, migration would be observed in Comet
assay.WhileBLMledtopositiveresponsesat0.0625μg/mL
onacellularassay,itledtonegativeresponsesat1.25μg/mL
on Comet assay. This discrepancy would be explained as
follows. Although rejoining of BLM-induced SSBs before the
preparationoftheCometassayreducespositiveresponseson
Comet assay, rejoining of BLM-induced SSBs does not occur
onacellularassaywherenoneofthecellularfunctionsremain
active. The induction of SSBs by BLM at 1.25μg/mL would
be too low to persist until the preparation of the Comet
assay, which would be responsible for the negative and
positive responses at 1.25μg/mL on Comet and acellular
assays, respectively. The Comet assay detects SSBs as initial
damage and SSBs formed through repairing process of
initial damage other than SSBs [1, 2, 4], while MN test
detects structural chromosome aberrations that are derived
from primary damage in the S phase and/or numerical
chromosome aberrations due to aneugenic eﬀects in the M
phase [6, 7]. Therefore, even if the SSB-induction level by
BLM is too low to persist until the preparation of the Comet
assay, SSBs that can persist until the start of the S phase
could form micronuclei, which could explain why LGDs are
detected on the order of MN test  Comet assay.
Comet assay detects SSBs produced as initial damage
as well as those generated during the repair of initial
damage such as alkylated bases, bulky base adducts, and
pyrimidine dimers [1, 2]. Therefore, in the case of mutagens
forming DNA adduct, the sensitivity of the Comet assay
is supported by the conversion eﬃciency of initial damage
into alkali-labile sites through the repair processes [1, 2].
Pyrimidine dimers, which are well known to be induced by
UVC, are removed by the nucleotide excision repair, which
involves incision of the DNA strand, excision of the damaged
nucleotide, gap ﬁlling by DNA resynthesis, and rejoining by
ligation. As shown by the negative responses on acellular
assay, it is considered that UVC does not induce SSBs as
initial damage [4]. As shown by the positive responsesJournal of Nucleic Acids 7
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Figure 4:Cometassayin0.5%LGTand1%LGT.ChinesehamsterCHOcellswereexposedtoeachchemicalmutagenfor1h,andthenslides
forCometassaywerepreparedimmediatelyaftertheexposure.ElectrophoresiswasconductedatpH > 13.4NQO,4-nitroquinoline-1-oxide;
AMD, actinomycin D
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on acellular assay; however, it is considered that not only
alkylated bases as initial damage but also SSBs as initial
damage are induced by alkylating agents [4]. (SSBs as initial
damage would not contribute markedly to positive responses
on Comet assay [4].) SSBs that are formed during the
process of repairing pyrimidine dimers and alkylated bases
are responsible for the DNA migration observed on Comet
assay [4]. SSB-rejoining, which reduces DNA migration, can
be canceled by incubation with DNA synthesis inhibitors
such as HU and araC, which block DNA resynthesis [5, 17].
LGDs of UVC and alkylating agents were MN test < Comet
assay, suggesting that SSBs formed from pyrimidine dimers
and alkylated bases that do not persist until the preparation
of the Comet assay can form micronuclei. However, LGDs
of UVC and alkylating agents were detected in the order
of Comet assay/araC < MN test, suggesting that not all
unrejoined SSBs form micronuclei and that the inhibition
of the rejoining step during excision repair can elevate the
power of the Comet assay to detect a low level of genotoxic
potential to a level higher than that of MN test.
LGDs of BLM and studied mutagens except for BLM
were 2.5-fold and 2-fold higher on Comet assay than
on MN test, respectively, which would suggest that the
power of the Comet assay to detect a low level of genotoxic
potential tended to be lower than that on MN test for
mutagens that easily produce SSBs as the initial damage.
This suggests that SSBs as initial damage might make a
greater contribution to micronucleus formation than to
DNA migration, considering our previous discussion that
SSBs as the initial damage would not contribute markedly
to positive responses on Comet assay [4]. Furthermore, it
is considered that the second step of repair events includes
gap ﬁlling by DNA resynthesis followed by ligation, which
reducesthe sensitivity on Comet assayto a level below thatof8 Journal of Nucleic Acids
MN test, though the progression of initial damage to alkali-
labile sites during the repair process is an important factor
contributing to the sensitivity on Comet assay.
In conclusion, the power of Comet assay to detect a
low level of genotoxicity is lower than that of MN test,
which concurs with the results reported by Pfau et al. [8].
For the studied mutagens, all assays (except for acellular
assay for UVC) were able to detect all mutagens correctly,
suggesting that the sensitivities of Comet assay and MN test
were exactly identical. For the studied mutagens; however,
LGDs on Comet assay were higher than those on MN test,
suggesting that the power of MN test to detect low level
of genotoxic potential is superior to that of Comet assay.
Higher LGDs on MN test would depend on the selection
of diﬀerent spectra of damage by the Comet assay and MN
test; that is, the formation of SSBs during repairing process is
an important factor leading to positive responses on Comet
assay and whether cells with unrepaired DNA damage can
entertheSphasetoformstructuralchromosomeaberrations
would be an important factor leading to positive responses
on MN test. Furthermore, whether LGDs on Comet assay
are lower or higher than those on MN test would depend on
which compounds are examined. Despite the lower power of
the Comet assay to detect a low level of genotoxic potential,
one of the most important advantages of the Comet assay
is that DNA damage can be measured in any cell type [19],
while the MN test is limited to cells having mitotic activity.
Furthermore, the power of Comet assay to detect a low level
of genotoxicity can be elevated to a level higher than that of
MN test by using DNA resynthesis inhibitors, such as araC
and HU.
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